By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

OncoSec Medical Inc. 

200 South Virginia Street
8th Floor
Reno  Nevada  89501  U.S.A.
Phone: 775-562-0504 Fax: n/a


SEARCH JOBS


Industry
Medical Device






Company News
OncoSec Medical Presents Preclinical Data Demonstrating Improved Systemic Anti-Tumor Response Following Modifications To IL-12 Gene Delivery Therapy At AACR Annual Meeting 4/3/2017 9:44:58 AM
OncoSec Medical's Intratumoral Plasmid IL-12 Demonstrates Effectiveness At Enhancing Tumor Immunogenicity In Preclinical Tumor Models 3/22/2017 7:20:27 AM
OncoSec Medical Announces Second Quarter And YTD Results For Fiscal Year 2017 3/17/2017 8:40:50 AM
OncoSec Medical Announces First Technology Access Program Agreement With Inhibrx 3/14/2017 8:55:19 AM
OncoSec Medical Granted FDA Fast Track Designation For Immunopulse IL-12 For The Treatment Of Metastatic Melanoma Following Progression On Pembrolizumab Or Nivolumab 2/27/2017 6:27:44 AM
OncoSec Medical Announces Positive Phase II Data Demonstrating Company's ImmunoPulse IL-12 In Combination With Pembrolizumab Increased Response Rates In Anti-PD-1 Non-Responder Melanoma Patients 2/23/2017 10:50:50 AM
OncoSec Medical Announces First Quarter Financial Results For Fiscal Year 2017 12/9/2016 7:22:37 AM
OncoSec Medical To Host First Quarter Financial Results Conference Call On December 8, 2016 11/15/2016 8:23:03 AM
OncoSec Medical Presents Positive Interim Response Data At The Society For Immunotherapy Of Cancer (SITC) Annual Meeting 2016 11/14/2016 8:24:20 AM
OncoSec Medical Announces Positive Interim Response Data At The Society For Immunotherapy Of Cancer (SITC) Annual Meeting 2016 11/9/2016 11:59:00 AM
12345678910...
//-->